Literature DB >> 3754714

Effects of cyclosporin on collagen induced arthritis in mice.

K Takagishi, N Kaibara, T Hotokebuchi, C Arita, M Morinaga, K Arai.   

Abstract

We have studied the effect of the immunosuppressive agent cyclosporin on collagen induced arthritis in mice. Cyclosporin, when given prophylactically, was capable of suppressing the development of collagen induced arthritis and the immunological response to native type II collagen in a dose dependent manner. Furthermore, treatment with cyclosporin, started on the same day as the booster injection with type II collagen, also resulted in inhibition of development of arthritis and of immunity to collagen. These findings suggest that the time of a booster injection, three weeks after the initial immunisation, might be still within the induction phase of arthritis since reinoculation is required to produce a high incidence of arthritis in mice. In addition, therapeutic treatment with cyclosporin did not affect the clinical course of the disease or the immune response to collagen.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3754714      PMCID: PMC1001880          DOI: 10.1136/ard.45.4.339

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  34 in total

1.  Enzyme immunoassays in diagnostic medicine. Theory and practice.

Authors:  A Voller; D E Bidwell; A Bartlett
Journal:  Bull World Health Organ       Date:  1976       Impact factor: 9.408

2.  Biological effects of cyclosporin A: a new antilymphocytic agent.

Authors:  J F Borel; C Feurer; H U Gubler; H Stähelin
Journal:  Agents Actions       Date:  1976-07

3.  Capacity of mycobacterial wax D and its subfractions to induce adjuvant arthritis in rats.

Authors:  F D Wood; C M Pearson; A Tanaka
Journal:  Int Arch Allergy Appl Immunol       Date:  1969

4.  Cyclosporin A and dexamethasone suppress T cell responses by selectively acting at distinct sites of the triggering process.

Authors:  E L Larsson
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

5.  Serum transfer of collagen arthritis to cyclosporin-treated, type II collagen-tolerant rats.

Authors:  N Kaibara; M Morinaga; C Arita; T Hotokebuchi; K Takagishi
Journal:  Clin Immunol Immunopathol       Date:  1985-05

6.  Effect of psychological stress on the induction of arthritis in rats.

Authors:  M P Rogers; D E Trentham; W J McCune; B I Ginsberg; H G Rennke; P Reich; J R David
Journal:  Arthritis Rheum       Date:  1980-12

7.  Immunisation against heterologous type II collagen induces arthritis in mice.

Authors:  J S Courtenay; M J Dallman; A D Dayan; A Martin; B Mosedale
Journal:  Nature       Date:  1980-02-14       Impact factor: 49.962

8.  Humoral and cellular sensitivity to collagen in type II collagen-induced arthritis in rats.

Authors:  D E Trentham; A S Townes; A H Kang; J R David
Journal:  J Clin Invest       Date:  1978-01       Impact factor: 14.808

9.  Studies on the immunosuppressive properties of cyclosporin a in rats receiving renal allografts.

Authors:  W P Homan; J W Fabre; K A Williams; P R Millard; P J Morris
Journal:  Transplantation       Date:  1980-05       Impact factor: 4.939

10.  Collagen-induced arthritis in rats. Evaluation of early immunologic events.

Authors:  J M Stuart; M A Cremer; A H Kang; A S Townes
Journal:  Arthritis Rheum       Date:  1979-12
View more
  14 in total

1.  Inhibition by FK506 of established lesions of collagen-induced arthritis in rats.

Authors:  C Arita; T Hotokebuchi; H Miyahara; K Arai; Y Sugioka; N Kaibara
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

2.  Effects of indomethacin, cyclosporin, cyclophosphamide, and placebo on collagen-induced arthritis of mice.

Authors:  G W Cannon; S McCall; B C Cole; M M Griffiths; L A Radov; J R Ward
Journal:  Agents Actions       Date:  1990-03

3.  Monoclonal antibodies and arthritis.

Authors:  M E Billingham; C Hicks; S Carney
Journal:  Agents Actions       Date:  1990-01

4.  Effects of a highly selective plasma kallikrein inhibitor on collagen-induced arthritis in mice.

Authors:  Y Fujimori; T Nakamura; K Shimizu; T Yamamuro; K Wanaka; S Okamoto; Y Katsuura
Journal:  Agents Actions       Date:  1993-05

5.  Effects of gold sodium thiomalate, cyclosporin A, cyclophosphamide, and placebo on collagen-induced arthritis in rats.

Authors:  G W Cannon; S McCall; B C Cole; L A Radov; J R Ward; M M Griffiths
Journal:  Agents Actions       Date:  1993-03

6.  The influence of a peptide sequence from PF-4 (CT-112) on type II collagen-induced arthritis in mice.

Authors:  P H Wooley; J D Whalen; J A Dutcher; D F Counts
Journal:  Inflamm Res       Date:  1995-08       Impact factor: 4.575

7.  Activation pathways of synovial T lymphocytes. Expression and function of the UM4D4/CDw60 antigen.

Authors:  D A Fox; J A Millard; L Kan; W S Zeldes; W Davis; J Higgs; F Emmrich; R W Kinne
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

8.  Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice.

Authors:  A P Kuruvilla; R Shah; G M Hochwald; H D Liggitt; M A Palladino; G J Thorbecke
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

Review 9.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

10.  Interleukin 1 mediated acceleration of type II collagen-induced arthritis: effects of anti-inflammatory or anti-arthritic drugs.

Authors:  J T Hom; V L Gliszczynski; H W Cole; A M Bendele
Journal:  Agents Actions       Date:  1991-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.